The use of zoledronic acid for paget’s disease of bone.
- Published in:
- Current Osteoporosis Reports, 2006, v. 4, n. 1, p. 40, doi. 10.1007/s11914-006-0014-5
- By:
- Publication type:
- Article
Works matching IS 15441873 AND DT 2006 AND VI 4 AND IP 1
Results: 7
1
2
Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.
- Published in:
- Current Osteoporosis Reports, 2006, v. 4, n. 1, p. 5, doi. 10.1007/s11914-006-0009-2
- By:
- Publication type:
- Article
3
Web alert.
- Published in:
- Current Osteoporosis Reports, 2006, v. 4, n. 1, p. 4, doi. 10.1007/s11914-006-0008-3
- Publication type:
- Article
4
Strontium ranelate—Data on vertebral and nonvertebral fracture efficacy and safety: Mechanism of action.
- Published in:
- Current Osteoporosis Reports, 2006, v. 4, n. 1, p. 34, doi. 10.1007/s11914-006-0013-6
- By:
- Publication type:
- Article
5
Inhibition of RANKL as a treatment for osteoporosis: Preclinical and early clinical studies.
- Published in:
- Current Osteoporosis Reports, 2006, v. 4, n. 1, p. 28, doi. 10.1007/s11914-006-0012-7
- By:
- Publication type:
- Article
6
Review of adherence to medications for the treatment of osteoporosis.
- Published in:
- Current Osteoporosis Reports, 2006, v. 4, n. 1, p. 21, doi. 10.1007/s11914-006-0011-8
- By:
- Publication type:
- Article
7
Ibandronate treatment for osteoporosis: Rationale, preclinical and clinical development of extended dosing regimens.
- Published in:
- Current Osteoporosis Reports, 2006, v. 4, n. 1, p. 14, doi. 10.1007/s11914-006-0010-9
- By:
- Publication type:
- Article